Clarity Pharmaceuticals Ltd (ASX:CU6)
3.660
+0.040 (1.10%)
Aug 15, 2025, 4:10 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.36 billion as of August 15, 2025. Its market cap has decreased by -19.71% in one year.
Market Cap
1.36B
Enterprise Value
1.25B
Revenue
10.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.66
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.36B, an increase of 254.32%. That is a compound annual growth rate of 37.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 1.36B | 1.76% |
Dec 31, 2024 | 1.34B | 168.49% |
Dec 29, 2023 | 498.26M | 93.82% |
Dec 30, 2022 | 257.07M | 35.63% |
Dec 31, 2021 | 189.54M | -50.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 130.79B |
Pro Medicus | 32.98B |
Cochlear | 20.01B |
Sonic Healthcare | 14.07B |
Ramsay Health Care | 9.02B |
Telix Pharmaceuticals | 5.76B |
Ansell | 4.58B |
Mesoblast | 3.11B |